MedPath

pharmacokinetics and pharmacodynamics study of intraveneous acetaminophe

Phase 3
Conditions
Patients who undergo head neck and oral surgery without nerve block or epidural anesthesia
Registration Number
JPRN-UMIN000030006
Lead Sponsor
Tohoku University
Brief Summary

As a result of examining the results of NRS in 3 groups and postoperative analgesics and the characteristics of the blood concentration transition curve, when intravenous APAP 1000 mg is used intraoperatively and postoperatively, the analgesic effect was high with the administration method that combined rapid single administration and continuous administration.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
51
Inclusion Criteria

Not provided

Exclusion Criteria

1.History of allergy to acetaminophen 2.History of aspirin asthma 3.Oral use of carbamazepine/phenobarbital/phenytoin/primidone/rifampicin 4.Psychoneurotic disorders 5.Psychiatric pharmacotherapy 6.Liver or advanced renal dysfunction 7.Alcohol drinkers and adddiction patient 8.Pregnant woman/breast-feeding 9.Those who were considered inadequate

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood concentration of acetaminophen
Secondary Outcome Measures
NameTimeMethod
VRS VAS NRS
© Copyright 2025. All Rights Reserved by MedPath